JP2012532134A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532134A5
JP2012532134A5 JP2012518575A JP2012518575A JP2012532134A5 JP 2012532134 A5 JP2012532134 A5 JP 2012532134A5 JP 2012518575 A JP2012518575 A JP 2012518575A JP 2012518575 A JP2012518575 A JP 2012518575A JP 2012532134 A5 JP2012532134 A5 JP 2012532134A5
Authority
JP
Japan
Prior art keywords
seq
nos
amino acid
polypeptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012518575A
Other languages
English (en)
Japanese (ja)
Other versions
JP5931724B2 (ja
JP2012532134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/040406 external-priority patent/WO2011008548A1/en
Publication of JP2012532134A publication Critical patent/JP2012532134A/ja
Publication of JP2012532134A5 publication Critical patent/JP2012532134A5/ja
Application granted granted Critical
Publication of JP5931724B2 publication Critical patent/JP5931724B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012518575A 2009-06-29 2010-06-29 ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物 Expired - Fee Related JP5931724B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US22154109P 2009-06-29 2009-06-29
US61/221,541 2009-06-29
US24059809P 2009-09-08 2009-09-08
US24061609P 2009-09-08 2009-09-08
US61/240,616 2009-09-08
US61/240,598 2009-09-08
US31626710P 2010-03-22 2010-03-22
US61/316,267 2010-03-22
PCT/US2010/040406 WO2011008548A1 (en) 2009-06-29 2010-06-29 Vaccines and compositions against streptococcus pneumoniae

Publications (3)

Publication Number Publication Date
JP2012532134A JP2012532134A (ja) 2012-12-13
JP2012532134A5 true JP2012532134A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP5931724B2 JP5931724B2 (ja) 2016-06-08

Family

ID=43449681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518575A Expired - Fee Related JP5931724B2 (ja) 2009-06-29 2010-06-29 ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物

Country Status (15)

Country Link
US (2) US10105412B2 (cg-RX-API-DMAC7.html)
EP (1) EP2448592B1 (cg-RX-API-DMAC7.html)
JP (1) JP5931724B2 (cg-RX-API-DMAC7.html)
KR (1) KR101748453B1 (cg-RX-API-DMAC7.html)
CN (2) CN102548572A (cg-RX-API-DMAC7.html)
AU (1) AU2010273708B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1011919A2 (cg-RX-API-DMAC7.html)
CA (1) CA2803061A1 (cg-RX-API-DMAC7.html)
IL (1) IL217166A0 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00791A (cg-RX-API-DMAC7.html)
MX (1) MX2012000158A (cg-RX-API-DMAC7.html)
NZ (1) NZ597858A (cg-RX-API-DMAC7.html)
RU (1) RU2580299C2 (cg-RX-API-DMAC7.html)
SG (2) SG10201403702SA (cg-RX-API-DMAC7.html)
WO (1) WO2011008548A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2580299C2 (ru) 2009-06-29 2016-04-10 Дженосеа Биосайенсиз, Инк. Вакцины и композиции, направленные против streptococcus pneumoniae
EP2550289A4 (en) 2010-03-12 2013-11-27 Childrens Medical Center NEW IMMUNOGENES AND METHODS FOR IDENTIFICATION AND SCREENING THEREOF
AU2011347266B2 (en) * 2010-12-21 2016-07-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Determination of the efficacy of an anti-mycobacterial vaccination
EP2665490B1 (en) * 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
UY33939A (es) * 2011-03-09 2012-09-28 Glaxosmithkline Llc Inhibidores de la péptido desformilasa
CA2835628C (en) * 2011-05-11 2023-01-03 Children's Medical Center Corporation Multiple antigen presenting immunogenic composition, and methods and uses thereof
US9765125B2 (en) 2012-01-20 2017-09-19 Genocea Biosciences, Inc. Fused antigen vaccines and compositions against Streptococcus pneumoniae
WO2014018904A1 (en) * 2012-07-26 2014-01-30 Genocea Biosciences, Inc. Fused antigen vaccines and compositions against streptococcus pneumoniae
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
US20150079132A1 (en) * 2013-09-17 2015-03-19 Path Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
WO2015161218A1 (en) * 2014-04-18 2015-10-22 Children's Medical Center Corporation Vaccine adjuvant compositions
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US11413344B2 (en) * 2017-01-20 2022-08-16 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN110730670A (zh) 2017-03-28 2020-01-24 儿童医疗中心有限公司 基于多抗原提呈系统(maps)的金黄色葡萄球菌疫苗、免疫原性组合物以及它们的用途
BR112019027387A8 (pt) 2017-06-23 2022-12-06 Univ Maryland Composições imunogênicas
CN111447948B (zh) 2017-12-04 2025-09-02 英特维特国际股份有限公司 具有复制子颗粒和油佐剂的疫苗
US20200087361A1 (en) 2018-09-12 2020-03-19 The Children's Medical Center Corporation Pneumococcal fusion protein vaccines
CA3111459A1 (en) 2018-09-12 2020-03-19 Affinivax, Inc. Multivalent pneumococcal vaccines
RU2728938C1 (ru) * 2020-05-06 2020-08-03 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Применение даларгина для производства лекарственных средств профилактики пневмонии
EP4181951A1 (en) 2020-07-16 2023-05-24 Zalvac AB Streptococcal vaccines
KR20240099160A (ko) 2021-09-09 2024-06-28 아피니백스, 인크. 다가 폐렴구균 백신

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
EP0907738A1 (en) 1996-04-02 1999-04-14 Smithkline Beecham Corporation Novel compounds
DK0942983T4 (en) 1996-10-31 2014-12-01 Human Genome Sciences Inc Streptococcus pneumoniae antigens and vaccines
AU735444B2 (en) 1997-05-06 2001-07-05 Human Genome Sciences, Inc. (Enterococcus faecalis) polynucleotides and polypeptides
WO1998059071A1 (en) 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en) * 1997-07-17 1999-03-16 Smithkline Beecham Corporation Glycogen phosphorylase
US5994101A (en) * 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
JP2002521058A (ja) 1998-07-27 2002-07-16 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌由来の核酸及びタンパク質
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
HK1043943A1 (zh) 1999-06-10 2002-10-04 Medimmune, Inc. 肺炎链球菌蛋白质和疫苗
US6951732B2 (en) * 1999-12-23 2005-10-04 Vmax Ltd. Virulence genes, proteins, and their use
US6783939B2 (en) 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
EP2277894A1 (en) * 2000-10-27 2011-01-26 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups A & B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
BR0208944A (pt) 2001-04-16 2006-10-10 Wyeth Corp quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
EP2275122A3 (en) 2002-04-02 2011-05-18 Ben Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US20090252756A1 (en) * 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
WO2004020609A2 (en) 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
AU2004230244B2 (en) * 2003-04-15 2011-09-22 Intercell Ag S. pneumoniae antigens
GB0318688D0 (en) * 2003-08-08 2003-09-10 Chiron Srl Streptococcus pneumoniae knockout mutants
JP2008525033A (ja) 2004-12-22 2008-07-17 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｂ群連鎖球菌
AU2006212602A1 (en) * 2005-02-11 2006-08-17 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides
AU2007225238A1 (en) * 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
PT2054431E (pt) * 2006-06-09 2011-11-03 Novartis Ag Confórmeros de adesinas bacterianas
GB0700136D0 (en) 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Process for manufacturing vaccines
WO2008119358A2 (en) 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
EP2155912B1 (en) 2007-05-18 2013-06-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Primers and probes for the detection of streptococcus pneumoniae
CN101848929A (zh) 2007-05-25 2010-09-29 诺华有限公司 肺炎链球菌菌毛抗原
US20100247547A1 (en) * 2007-05-29 2010-09-30 Chen Dong Modulation of the th-17 cell mediated immune responses
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20100278819A1 (en) * 2007-09-14 2010-11-04 Katholieke Universiteit Leuven Streptococcus pneumoniae vaccines
US7833776B2 (en) * 2007-12-12 2010-11-16 National Health Research Institutes Lipidating sequences and use thereof for producing lipidated proteins in E. coli
US8466259B2 (en) * 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
US8815564B2 (en) * 2008-03-14 2014-08-26 Sanofi Pasteur Biologics, Llc Replication-defective flavivirus vaccines and vaccine vectors
US8313894B2 (en) 2008-07-01 2012-11-20 Genocea Biosciences, Inc. Antigen screening system
BRPI0922132A2 (pt) 2008-12-03 2018-10-23 Protea Vaccine Tech Ltd fragmentos glutamil trna sintetase (gts).
US8287880B2 (en) * 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
CN102482327B (zh) * 2009-06-22 2014-10-29 财团法人卫生研究院 脂质化肿瘤相关抗原及其免疫治疗的组成物及方法
WO2010150242A2 (en) 2009-06-25 2010-12-29 Protea Vaccine Technologies Ltd. Immunogenic streptococcus pneumoniae peptides and peptide-multimers
RU2580299C2 (ru) 2009-06-29 2016-04-10 Дженосеа Биосайенсиз, Инк. Вакцины и композиции, направленные против streptococcus pneumoniae
WO2011064781A1 (en) 2009-11-30 2011-06-03 Ben-Gurion University Of The Negev Research And Development Authority S. pneumoniae adhesins
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (ja) * 2010-04-06 2012-10-31 株式会社日立製作所 管理方法及び管理装置
WO2011128892A2 (en) 2010-04-12 2011-10-20 Protea Vaccine Technologies Ltd. Modified forms of pneumococcal surface immunogenic protein b (psipb)
WO2011141968A1 (en) 2010-05-14 2011-11-17 Hitachi, Ltd. Storage apparatus and data retaining method for storage apparatus
EP2665490B1 (en) * 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Similar Documents

Publication Publication Date Title
JP2012532134A5 (cg-RX-API-DMAC7.html)
RU2011153032A (ru) Вакцины и композиции, направленные против streptococcus pneumoniae
ES2741729T3 (es) Vectores y construcciones de liberación de antígenos de virus de la gripe
CA2632483C (en) Improved influenza vaccine
RU2013138563A (ru) Вакцины и композиции против streptococcus pneumoniae
JP2008530245A5 (cg-RX-API-DMAC7.html)
JP2012136541A5 (cg-RX-API-DMAC7.html)
JP2020023567A5 (cg-RX-API-DMAC7.html)
JP2014534202A5 (cg-RX-API-DMAC7.html)
NZ601345A (en) Combination adjuvant formulation
JP2016502551A5 (cg-RX-API-DMAC7.html)
JP2011524737A5 (cg-RX-API-DMAC7.html)
JP2014521605A5 (cg-RX-API-DMAC7.html)
CN1578672A (zh) Rsv基因表达疫苗
JP2010532656A5 (cg-RX-API-DMAC7.html)
RU2013126888A (ru) ИММУНОМОДУЛИРУЮЩИЕ КОМПОЗИЦИИ, СПОСОБЫ И СИСТЕМЫ, СОДЕРЖАЩИЕ ИММУНОГЕННЫЕ ФРАГМЕНТЫ АроВ100
JP2011522777A5 (cg-RX-API-DMAC7.html)
JP2015513314A5 (cg-RX-API-DMAC7.html)
JP2013523084A5 (cg-RX-API-DMAC7.html)
Zhang et al. The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control
JP2018135388A (ja) シュードモナス抗原および抗原の組み合わせ
JP2014515595A5 (cg-RX-API-DMAC7.html)
WO2012162637A3 (en) Vaccine adjuvants from self-assembling peptides
Schulze et al. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
JP2011514167A5 (cg-RX-API-DMAC7.html)